Recurrent hepatitis C genotype 1b following liver transplantation: Treatment with combination interferon-ribavirin therapy

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 11, 2004, Pages 1207-1212

  Berenguer, Marina ^a   Prieto, Martín ^a   Palau, Antonio ^a   Carrasco, Domingo ^a   Rayón, José Miguel ^a   Calvo, Félix ^a   Berenguer, Joaquín ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cirrhosis; Hepatitis C virus; Immunosuppression; Interferon; Liver transplantation; Retransplantation; Ribavirin

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; CYCLOSPORIN A; INTERFERON; RIBAVIRIN;

ACUTE GRAFT REJECTION; ACUTE HEPATITIS; ADULT; AGED; ANEMIA; ARTICLE; BIOCHEMISTRY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEMALE; FIBROSIS; GENOTYPE; HEART DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; VIROLOGY;

ACUTE DISEASE; ADULT; AGED; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 8444224644     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200411000-00020     Document Type: Article

References (24)

1. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35:666-678.
2. Prieto M, Berenguer M, Rayón M, Córdoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29:250-256.
3. Gane E, Portmann B, Naoumov N, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815-820.
4. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6:553-561.
5. Feray C, Caccamo L, Alexander GJM, Ducot B, Gugenheim J, Casanovas T, et al. European Collaborative Study on factors influencing the outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117:619-625.
6. Sanchez-Fueyos A, Restrepo J-C, Quintó L, Bruguera M, Grande L, Sanchez-Tapias JM, et al. Impact of the recurrence of hepatitis C infection after liver transplantation on the long term viability of the graft. Transplantation 2002; 73:56-63.
7. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32:673-684.
8. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36:202-210.
9. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889-896.
10. Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, et al. Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation. Hepatology 2000; 32:852-858.
11. Wright TL, Combs C, Kim M, Ferell L, Bachetti P, Ascher N, et al. Interferon alpha therapy for hepatitis C virus infection following liver transplantation. Hepatology 1994; 20:773-779.
12. Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22:1084-1089.
13. Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JYN, Naoumov NV, Williams R. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27:1403-1407.
14. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26:500-504.
15. Alberti AB, Belli LS, Airoldi A, De Carlis L, Rondinara G, Minola E, et al. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver Transpl 2001; 7:870-876.
16. Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001; 7:181-190.
17. Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 2001; 7:863-869.
18. De Vera ME, Smallwood GA, Rosado K, Davis L, Martinez E, Sharma S, et al. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation. Transplantation 2001; 71:678-686.
19. Narayanan M, Poterucha JJ, El-Amin OM, Burgart LJ, Kremers WK, Rosen CH, et al. Treatment of post transplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl 2002; 8:623-629.
20. Saab S, Ly D, Han SB, Lin RK, Rojter SE, Ghobrial RM, Busuttil RW. Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? Liver Transpl 2002; 8:449-457.
21. Lavezzo B, Franchello A, Smedile A, Ottobreli A, Ghisetti V, Franchello A, et al. Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus twelve month course of interferon alfa 2b with ribavirin. J Hepatol 2002; 37:247-252.
22. Andreone P, Gramenzi A, Cursaro C, Biselli M, Di Giammarino L, Grazi GL, et al. Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study. Digest Liver Dis 2001; 33:693-698.
23. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SNS, Lemonnier C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124:642-650.
24. Mazzaferro V, Tagger A, Schiavo M, Regalia E, Pulvirenti A, Ribero ML, et al. Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transpl Proc 2001; 33: 1355-1357.